Formulary Chapter 3: Respiratory system - Full Chapter
|
Notes: |
Inhalers should always be prescribed by their BRAND name.
The patient's ability to use a device should be assessed by a competent healthcare professional and re-assessed as part of structured clinical review. If the patient is unable to use a device satisfactorily, an alternative should be found.
RightBreathe is a free app/website designed to help clinicians and patients use inhaled therapy and devices appropriately https://www.rightbreathe.com/. Asthma.org has patient-friendly videos of inhaler technique here.
In children aged 0-5 years, pMDI and spacer are the preferred delivery method for β2 agonists or inhaled steroids. A face mask is required until the child can breathe reproducibly using the spacer mouthpiece.
Self-care
Many of the products in this chapter are available for purchase over-the-counter, and patients are encouraged to self-care, with the support of their community pharmacist, in the first instance. For further information on self-care & the NHS, please refer to https://www.england.nhs.uk/medicines/conditions-for-which-over-the-counter-items-should-not-routinely-be-prescribed/
|
|
|
03.04.01 |
Non-sedating antihistamines |
|
|
03.04.01 |
Sedating antihistamines |
|
|
Alimemazine
(Vallergan®)

|
Non Formulary
|
- Please note alimemazine has been removed from formulary,
as it is prohibitively expensive.
- Prescribers are asked to utilise other formulary options.
|
Cyproheptadine
(Periactin®)

|
Non Formulary
|
|
Diphenhydramine
(Nytol® Simply Sleep Hot Chocolate)

|
Non Formulary
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
High Cost Drug Approval System |
|
Traffic Light Status Information
|
|